Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

carcinoma poorly differentiated

Known as: poorly differentiated carcinoma 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BackgroundPrecision medicine approaches are ideally suited for rare tumors where comprehensive characterization may have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
Histological and cytological criteria in predicting clinical outcomes in patients with oncocytic poorly differentiated carcinoma… Expand
2012
2012
Previous evidence suggests soy genistein may be protective against prostate cancer, but whether this protection involves an… Expand
2011
2011
BackgroundACC can occasionally undergo dedifferentiation also referred to as high-grade transformation (ACC-HGT). However, ACC… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2002
Highly Cited
2002
Patients with an unknown primary tumour (UPT) represent 5-10% of all new cancer patients. Data on survival and prognostic factors… Expand
Highly Cited
1997
Highly Cited
1997
PURPOSE The objectives of this study were to assess clinical outcomes and prognostic factors in unselected, consecutive patients… Expand
Highly Cited
1997
Highly Cited
1997
PURPOSE To evaluate the efficacy and toxicity of a novel chemotherapy combination that includes paclitaxel, carboplatin, and… Expand
Highly Cited
1996
Highly Cited
1996
The pattern of p53 protein expression was examined in 92 cases of thyroid carcinoma. When the cases were divided into two groups… Expand
Highly Cited
1994
Highly Cited
1994
The expression of bcl-2 and p53 was investigated by immunocytochemistry in combination with that of conventional structural and… Expand
Highly Cited
1992
Highly Cited
1992
PURPOSE We previously reported excellent responses to cisplatin-based chemotherapy in a minority of patients with poorly… Expand